President Trump’s announcement of new tariffs on semiconductors and pharmaceuticals kept markets in flux. Plus: Drugmaker Pfizer boosted its annual profit guidance. And, data-software company Palantir ...

The stock slipped 3.5% postmarket after the chip maker reported adjusted earnings per share in line with estimates.